Role of the control radiological examination in active detection of TB and lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 423s Year: 2005
Comparison of smear positive tuberculosis features in males with and without chronic lung diseases Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Factors affecting sputum conversion time in patients with smear positive tuberculosis Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Predictive factors of sequelae among Tunisian patients treated for pulmonary tuberculosis. Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018
Factors associated with sputum culture conversion in patients with pulmonary tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
Predictive factors of delayed sputum conversion in pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
Impact of social of social risk factor on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Treatment outcomes of smear positive pulmonary tuberculosis cases Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011
The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006
A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 6s Year: 2006
A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis control Year: 2010
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Collapso-surgical treatment of patients with diffused destructive tuberculosis of the lungs Source: Eur Respir J 2002; 20: Suppl. 38, 343s Year: 2002
Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002